September 10th - 12th, 2021

  • Further information follow

Guideline for Abstract

FREE PAPER PRESENTERS NEED TO BE REGISTERED AS A DELEGATE

Please kindly pay attention to following guidelines:

• Abstracts must be submitted and presented only in English.
• Individuals should submit material only if they, or a designee, are committed to registering
• There is no limit to the number of abstracts you may submit.
• There are two types of presentations: oral and E-poster presentation by Virtual.
• All abstracts must have conclusion/results completed by the submission date. Abstracts describing data that have not yet been collected and/or analyzed as of the abstract deadline will be rejected
• You may indicate your presentation preference (oral or E-poster). The Abstract Selection Committee determines the final presentation format.
• Abstracts may be edited until the deadline for submission. After that date, no changes in content or authors may be made. Edits would include changing the title, adding or deleting authors or changing the abstract body. Once the review process begins, no changes to the submissions are allowed; no exceptions.
• Abstracts selected for the 5th ISMINS cannot contain advertising, trade names or a product-group messages. Please include generic names or terms in your abstract content.
• Main Author — Individual who is submitting the abstract. All correspondence will be done with the main author.
• Title
• Keywords (up to four).
• Abstract Body (300-word maximum) separated into:
  • Objectives - At least two clear, and measurable learning objectives must be included with your abstract submission. Learning objectives are not included in the abstract word count.
  • Background – A brief statement on why the study was conducted
  • Methods – The method(s) of study or experimental approach must be briefly defined.
  • Results – A summary of the study results, including sufficient details to support those conclusions must be described.
  • Conclusions – A statement explaining the significance of the work and its implications for further research.
• List Authors — Up to 11 list authors can be included. Their full names with credentials, city and state or country must be included.
• Disclosure of conflict of interest — This is required for presenting author, as well as agreement with Terms and Conditions.
• Submissions will be reviewed and scored by independent reviewers to ensure high quality scientific submissions are selected for presentation at the meeting. The following criteria will be used to score submissions:
  • Title: clear description of presentation and its contents
  • Conciseness, coherence, clarity and focus of presentation
  • Innovativeness of ideas, methods and or approach
  • Methodology: research design if an empirical study, including clearly stated questions, data sources, data collection procedures, analytic approach and results.
  • Relevance, currency, appropriateness and significance of the topics/issue/problem
• Notifications of the Abstract Selection Committee's decision will be sent July 30th, 2021 via email to the corresponding authors of all abstracts, regardless of the outcome.
• As Presenting Author, if you accept to present either an Oral Presentation or E-Poster, you must register and attend the 5th ISMINS. Registration must be completed by August 30th,2021. If the presenting author does not complete registration by above date all accepted abstracts submitted by the presenting author will be declined.
• If you are unable to Presented, a Change of Presenting Author Form must be completed and submitted by the registration deadline and not refundable. The new Presenting Author must then fulfill the registration requirement or the abstract will be declined.

Submission for Abstract

Abstract submission has been closed

Further Information
Congress

Secretariat

Ms. Ririen

Komplek Perkantoran Duta Merlin Blok C 35 - 38 Jl. Gajah Mada 3-5, Jakarta Pusat

ismins2021@pharma-pro.com

ririn@pharma-pro.com

+6221 – 63869502 | +62 811-1609-822